{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:48:14Z","timestamp":1770418094100,"version":"3.49.0"},"reference-count":28,"publisher":"Bentham Science Publishers Ltd.","issue":"3","funder":[{"DOI":"10.13039\/100012829","name":"Guangdong Province Hospital of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["YN2019MJ06"],"award-info":[{"award-number":["YN2019MJ06"]}],"id":[{"id":"10.13039\/100012829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012829","name":"Guangdong Province Hospital of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["YN2016MJ08"],"award-info":[{"award-number":["YN2016MJ08"]}],"id":[{"id":"10.13039\/100012829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005891","name":"State Administration of Traditional Chinese Medicine Clinical Base Fund","doi-asserted-by":"publisher","award":["JDZX2015206"],"award-info":[{"award-number":["JDZX2015206"]}],"id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDD"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Astilbin is a promising candidate drug for psoriasis. However, the poor solubility and stability limited its clinical application.<\/jats:p><\/jats:sec><jats:sec><jats:title>Purpose:<\/jats:title><jats:p>The present work aimed to develop a stable microemulsion of astilbin formulation and evaluate its effect in vitro and in vivo.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Oil phase, surfactants, and cosurfactants were screened using solubility and stability of astilbin as the index. The central composite experiment design and response surface methodology analysis were adopted to optimize microemulsion parameters. The particle size, zeta potential, polydispersity index, viscosity, drug content, encapsulation, transmission electron microscopy (TEM), and stability of the optimized microemulsion were evaluated. Then, the drug release and anti-psoriasis effects were evaluated in a mouse model induced by imiquimod.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>The optimum formulation contained Labrafil M 1944 Cs (10.12%), Polyoxyethylene Castor Oil 35 (37.41%), propylene glycol (12.47%), water (40%), and gallic acid (2.9%), and the average particle size was 14.71 nm. The permeability of astilbin from the optimized astilbin-gallic acid microemulsion in 24 hr was 4.39 times higher compared with the astilbin\u2019s microemulsion. The content of astilbin in astilbin-gallic acid microemulsion remained unchanged after being stored at 25\u00b0C for 4 months compared with astilbin aqueous (3 h) and astilbin microemulsion (185 h). Compared with the model group, the optimized formulation decreased the PASI score and Baker score by 49% and 73%, respectively, which showed a favorable anti-psoriasis effect. Moreover, there was no difference in the anti-psoriasis effect between the optimized group and the positive control.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>These results indicated that the astilbin-gallic acid microemulsion might be a potential topical drug used for the treatment of psoriasis.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1567201819666220425092114","type":"journal-article","created":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T08:30:11Z","timestamp":1650961811000},"page":"281-291","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Optimization of the Transdermal Delivery System in Astilbin Microemulsion with Improved Stability and Anti-psoriatic Activity"],"prefix":"10.2174","volume":"20","author":[{"given":"Yang","family":"Wang","sequence":"first","affiliation":[{"name":"School of Pharmacy, Tianjin University of Traditional Chinese Medicine, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruizhi","family":"Zhao","sequence":"first","affiliation":[{"name":"The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Neihuan Xilu, Guangzhou Higher Education Mega Center, Guangzhou, 510006, China"},{"name":"Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine, Syndrome, Neihuan Xilu, Guangzhou Higher Education Mega Center, Guangzhou, 510006, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutong","family":"Ding","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Neihuan Xilu, Guangzhou Higher Education Mega Center, Guangzhou, 510006, China"},{"name":"School of Pharmacy, Tianjin University of Traditional Chinese Medicine, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Liu","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Neihuan Xilu, Guangzhou Higher Education Mega Center, Guangzhou, 510006, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yayun","family":"Wu","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Neihuan Xilu, Guangzhou Higher Education Mega Center, Guangzhou, 510006, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"377","volume":"133","author":"Papp K.A.","year":"2021","unstructured":"Papp K.A.; Gniadecki R.; Beecker J.; Dutz J.; Gooderhan M.J.; Hong C.H.; Kirchhof M.G.; Lynde C.W.; Maari C.; Poulin Y.; Vender R.B.; Psoriasis prevalence and severity by expert eicitation. Dermatol Ther (Heidelb) 2021,133(2),377-385","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/bjd.18245","volume":"182","author":"Korman N.J.","year":"2020","unstructured":"Korman N.J.; Management of psoriasis as a systemic disease: What is the evidence? Br J Dermatol 2020,182(4),840-848","journal-title":"Br J Dermatol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1111\/jdv.15065","volume":"32","author":"Armstrong A.","year":"2018","unstructured":"Armstrong A.; Jarvis S.; Boehncke W.H.; Rajagopalan M.; Fern&#xE1;ndez-Pe&#xF1;as P.; Romiti R.; Bewley A.; Vaid B.; Huneault L.; Fox T.; Sodha M.; Warren R.B.; Patient perceptions of clear\/almost clear skin in moderate-to-severe plaque psoriasis: Results of the Clear About Psoriasis worldwide survey. J Eur Acad Dermatol Venereol 2018,32(12),2200-2207","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2340\/00015555-2834","volume":"98","author":"Schaarschmidt M.L.","year":"2018","unstructured":"Schaarschmidt M.L.; Herr R.; Gutknecht M.; Wroblewska K.; Gerdes S.; Sticherling M.; Augustin M.; Peitsch W.K.; Patients\u2019 and physicians\u2019 preferences for systemic psoriasis treatments: A nationwide comparative discrete choice experiment (PsoCompare). Acta Derm Venereol 2018,98(2),200-205","journal-title":"Acta Derm Venereol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.intimp.2017.01.023","volume":"44","author":"Han L.","year":"2017","unstructured":"Han L.; Sun J.; Lu C.J.; Zhao R.Z.; Lu Y.; Lin H.J.; Wei J.A.; Formula PSORI-CM01 inhibits the inflammatory cytokine and chemokine release in keratinocytes via NF-&#x3BA;B expression. Int Immunopharmacol 2017,44,226-233","journal-title":"Int Immunopharmacol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s11655-012-1020-3","volume":"18","author":"Lu C.J.","year":"2012","unstructured":"Lu C.J.; Xiang Y.; Xie X.L.; Xuan M.L.; He Z.H.; A randomized controlled single-blind clinical trial on 84 outpatients with Psoriasis vulgaris by auricular therapy combined with optimized Yinxieling Formula. Chin J Integr Med 2012,18(3),186-191","journal-title":"Chin J Integr Med"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.intimp.2008.06.006","volume":"8","author":"Yi H.W.","year":"2008","unstructured":"Yi H.W.; Lu X.M.; Fang F.; Wang J.; Xu Q.; Astilbin inhibits the adhesion of T lymphocytes via decreasing TNF-&#x3B1; and its associated MMP-9 activity and CD44 expression. Int Immunopharmacol 2008,8(10),1467-1474","journal-title":"Int Immunopharmacol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.1016\/j.transproceed.2010.06.031","volume":"42","author":"Zou S.","year":"2010","unstructured":"Zou S.; Shen X.; Tang Y.; Fu Z.; Zheng Q.; Wang Q.; Astilbin suppresses acute heart allograft rejection by inhibiting maturation and function of dendritic cells in mice. Transplant Pro 2010,42(9),3798-3802","journal-title":"Transplant Pro"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"e0124002","DOI":"10.1371\/journal.pone.0124002","volume":"10","author":"Guo L.","year":"2015","unstructured":"Guo L.; Liu W.; Lu T.; Guo W.; Gao J.; Luo Q.; Wu X.; Sun Y.; Wu X.; Shen Y.; Xu Q.; Decrease of functional activated T and B cells and treatment of glomerulonephitis in lupus-prone mice using a natural flavonoid astilbin. PLoS One 2015,10(4),e0124002","journal-title":"PLoS One"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.intimp.2015.12.035","volume":"32","author":"Di T.T.","year":"2016","unstructured":"Di T.T.; Ruan Z.T.; Zhao J.X.; Wang Y.; Liu X.; Wang Y.; Li P.; Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB\/c mice via Jak3\/Stat3 signaling pathway. Int Immunopharmacol 2016,32,32-38","journal-title":"Int Immunopharmacol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.biopha.2017.05.127","volume":"93","author":"Zhang C.","year":"2017","unstructured":"Zhang C.; Xu Q.; Tan X.; Meng L.; Wei G.; Liu Y.; Zhang C.; Astilbin decreases proliferation and improves differentiation in HaCaT keratinocytes. Biomed Pharmacother 2017,93,713-720","journal-title":"Biomed Pharmacother"},{"key":"ref=12","first-page":"3789","volume":"17","author":"Yu J.","year":"2018","unstructured":"Yu J.; Xiao Z.; Zhao R.; Lu C.; Zhang Y.; Astilbin emulsion improves guinea pig lesions in a psoriasis-like model by suppressing IL-6 and IL-22 via p38 MAPK. Mol Med Rep 2018,17(3),3789-3796","journal-title":"Mol Med Rep"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40659-019-0255-2","volume":"52","author":"Wang W.","year":"2019","unstructured":"Wang W.; Yuhai ; Wang H.; Chasuna ; ; Bagenna Astilbin reduces ROS accumulation and VEGF expression through Nrf2 in psoriasis-like skin disease. Biol Res 2019,52(1),49","journal-title":"Biol Res"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"104894","DOI":"10.1016\/j.phrs.2020.104894","volume":"158","author":"Sharma A.","year":"2020","unstructured":"Sharma A.; Gupta S.; Chauhan S.; Nair A.; Sharma P.; Astilbin: A promising unexplored compound with multidimentional medicinal and health benefits. Pharmacol Res 2020,158,104894","journal-title":"Pharmacol Res"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"12085","DOI":"10.1021\/jf404420s","volume":"61","author":"Zhang Q.F.","year":"2013","unstructured":"Zhang Q.F.; Fu Y.J.; Huang Z.W.; Shangguang X.C.; Guo Y.X.; Aqueous stability of astilbin: Effects of pH, temperature, and solvent. J Agric Food Chem 2013,61(49),12085-12091","journal-title":"J Agric Food Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules25204728","volume":"25","author":"Zheng D.","year":"2020","unstructured":"Zheng D.; Ruan Y.T.; Yin Z.P.; Zhang Q.F.; A comparasion of solubility, stablity, and bioavailability between astilbin and neoastilbin isolated from Smilax glabra Rhizoma. Molecules 2020,25(20),1-13","journal-title":"Molecules"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"5746","DOI":"10.1021\/acs.jafc.9b00018","volume":"67","author":"Zheng D.","year":"2019","unstructured":"Zheng D.; Zhang Q.F.; Bioavailability enhancement of astilbin in rats through zein-caseinate nanoparticles. J Agric Food Chem 2019,67(20),5746-5753","journal-title":"J Agric Food Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1111\/jphp.13282","volume":"72","author":"Shi M.","year":"2020","unstructured":"Shi M.; Xu M.; Yin L.; Pharmacokinetic, bioavailability and tissue distribution study of astilbin in rats. J Pharm Pharmacol 2020,72(8),1061-1071","journal-title":"J Pharm Pharmacol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"584","DOI":"10.15171\/apb.2019.067","volume":"9","author":"Mohammad Soleymani S.","year":"2019","unstructured":"Mohammad Soleymani S.; Salimi A.; Salimi A.; Enhancement of dermal delivery of finasteride using microemulsion systems. Adv Pharm Bull 2019,9(4),584-592","journal-title":"Adv Pharm Bull"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1208\/s12249-014-0275-8","volume":"16","author":"Coneac G.","year":"2015","unstructured":"Coneac G.; Vlaia V.; Olariu I.; Mu\u0163 A.M.; Anghel D.F.; Ilie C.; Popoiu C.; Lupuleasa D.; Vlaia L.; Development and evaluation of new microemulsion-based hydrogel formulations for topical delivery of fluconazole. AAPS PharmSciTech 2015,16(4),889-904","journal-title":"AAPS PharmSciTech"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms20061475","volume":"20","author":"Rendon A.","year":"2019","unstructured":"Rendon A.; Sch&#xE4;kel K.; Psoriasis pathogenesis and treatment. Int J Mol Sci 2019,20(6),1-28","journal-title":"Int J Mol Sci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1021\/jf304398v","volume":"61","author":"Zhang Q.F.","year":"2013","unstructured":"Zhang Q.F.; Nie H.C.; Shangguang X.C.; Yin Z.P.; Zheng G.D.; Chen J.G.; Aqueous solubility and stability enhancement of astilbin through complexation with cyclodextrins. J Agric Food Chem 2013,61(1),151-156","journal-title":"J Agric Food Chem"},{"key":"ref=23","first-page":"1626","volume":"43","author":"Wang X.H.","year":"2018","unstructured":"Wang X.H.; Zhong R.N.; Shen B.D.; Shen C.Y.; Liu X.; Dai B.; Yuan H.L.; Preparation of astilbin amorphous nanosuspension and its in vitro evaluation. Zhongguo Zhongyao Zazhi 2018,43(8),1626-1632","journal-title":"Zhongguo Zhongyao Zazhi"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1002\/jps.23958","volume":"103","author":"Ren Q.","year":"2014","unstructured":"Ren Q.; Deng C.; Meng L.; Chen Y.; Chen L.; Sha X.; Fang X.; In vitro, ex vivo, and in vivo evaluation of the effect of saturated fat acid chain length on the transdermal behavior of ibuprofen-loaded microemulsions. J Pharm Sci 2014,103(6),1680-1691","journal-title":"J Pharm Sci"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"119415","DOI":"10.1016\/j.ijpharm.2020.119415","volume":"586","author":"Zhang D.","year":"2020","unstructured":"Zhang D.; Ye D.; Jing P.; Tan X.; Qiu L.; Li T.; Shen L.; Sun Y.; Hou H.; Zhang Y.; Tian Q.; Design, optimization and evaluation of co-surfactant free microemulsion-based hydrogel with low surfactant for enhanced transdermal delivery of lidocaine. Int J Pharm 2020,586,119415","journal-title":"Int J Pharm"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000489524","volume":"54","author":"Bigliardi P.L.","year":"2018","unstructured":"Bigliardi P.L.; Skin pH in Psoriasis. Curr Probl Dermatol 2018,54,108-114","journal-title":"Curr Probl Dermatol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/1346-8138.14489","volume":"45","author":"Proksch E.","year":"2018","unstructured":"Proksch E.; pH in nature, humans and skin. J Dermatol 2018,45(9),1044-1052","journal-title":"J Dermatol"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/ptr.4894","volume":"27","author":"Basu S.","year":"2013","unstructured":"Basu S.; Jana S.; Patel V.B.; Patel H.; Effects of piperine, cinnamic acid and gallic acid on rosuvastatin pharmacokinetics in rats. Phytother Res 2013,27(10),1548-1556","journal-title":"Phytother Res"}],"container-title":["Current Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567201819666220425092114","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/203982\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567201819666220425092114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T16:31:37Z","timestamp":1700497897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/203982\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567201819666220425092114","relation":{},"ISSN":["1567-2018"],"issn-type":[{"value":"1567-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-10-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}